Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -82.49% is 42% above its 5-year average of -141.34%, near the high end of its 5-year range (-1146.81%–47.42%).
4.45% above its 12-month average of -86.34%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -114.70%.
NET PROFIT MARGIN
-82.49%
NET PROFIT MARGIN AVG TTM
-86.34%
NET PROFIT MARGIN AVG 3Y
-119.25%
NET PROFIT MARGIN AVG 5Y
-141.34%
NET PROFIT MARGIN AVG 10Y
-126.67%
NET PROFIT MARGIN AVG 15Y
-146.68%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4.45%
CURRENT VS 3Y AVG
+30.82%
CURRENT VS 5Y AVG
+41.64%
CURRENT VS 10Y AVG
+34.88%
CURRENT VS 15Y AVG
+43.76%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 749 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pacific Biosciences of California, Inc.
Market Cap
$833.97M
Net Profit Margin
-82.49%
TTM Avg
-86.34%
3Y Avg
-119.25%
5Y Avg
-141.34%
Market Cap
$842.21M
Net Profit Margin
-61.32%
TTM Avg
-78.55%
3Y Avg
-9174.62%
5Y Avg
-9174.62%
Market Cap
$837.51M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$852.85M
Net Profit Margin
-39.20%
TTM Avg
-57.59%
3Y Avg
-24.68%
5Y Avg
-1.42%
Market Cap
$845.98M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$844.79M
Net Profit Margin
-560.85%
TTM Avg
-63.69%
3Y Avg
-31.84%
5Y Avg
-21.23%
Market Cap
$821.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$857.96M
Net Profit Margin
-173.85%
TTM Avg
-104.63%
3Y Avg
-54.62%
5Y Avg
-54.62%
Market Cap
$809.02M
Net Profit Margin
-12.35%
TTM Avg
-13.43%
3Y Avg
-52.20%
5Y Avg
-503.49%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | $833.97M | -82.49% | -86.34% | -119.25% | -141.34% |
| Beta Bionics, Inc. (BBNX)vs › | $842.21M | -61.32% | -78.55% | -9174.62% | -9174.62% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $837.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| QuidelOrtho Corporation (QDEL)vs › | $852.85M | -39.20% | -57.59% | -24.68% | -1.42% |
| Alumis Inc. (ALMS)vs › | $845.98M | -5933.45% | -505.88% | -252.94% | -252.94% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $844.79M | -560.85% | -63.69% | -31.84% | -21.23% |
| Jade Biosciences, Inc. (JBIO)vs › | $821.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | -173.85% | -104.63% | -54.62% | -54.62% |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | -12.35% | -13.43% | -52.20% | -503.49% |
| InMode Ltd. (INMD)vs › | $806.17M | 20.69% | 35.62% | 36.75% | 38.26% |
Operating Margin
-348.5%
Net Profit Margin
-82.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -114.70% |
| 2026-03-31 | -22.26% |
| 2025-12-31 | -90.43% |
| 2025-09-30 | -98.85% |
| 2025-06-30 | -105.44% |
| 2025-03-31 | -1146.81% |
| 2024-12-31 | 6.04% |
| 2024-09-30 | -151.94% |
| 2024-06-30 | -481.27% |
| 2024-03-31 | -201.44% |
| 2023-12-31 | -140.55% |
| 2023-09-30 | -120.07% |
| 2023-06-30 | -146.79% |
| 2023-03-31 | -226.26% |
| 2022-12-31 | -308.50% |
| 2022-09-30 | -238.22% |
| 2022-06-30 | -201.30% |
| 2022-03-31 | -245.68% |
| 2021-12-31 | -192.48% |
| 2021-09-30 | 47.42% |
| 2021-06-30 | -133.95% |
| 2021-03-31 | -301.53% |
| 2020-12-31 | 276.15% |
| 2020-09-30 | -124.24% |
| 2020-06-30 | -135.19% |
| 2020-03-31 | 8.09% |
| 2019-12-31 | -0.33% |
| 2019-09-30 | -132.89% |
| 2019-06-30 | -99.90% |
| 2019-03-31 | -184.62% |
| 2018-12-31 | -157.73% |
| 2018-09-30 | -137.91% |
| 2018-06-30 | -104.46% |
| 2018-03-31 | -124.88% |
| 2017-12-31 | -83.26% |
| 2017-09-30 | -93.53% |
| 2017-06-30 | -127.23% |
| 2017-03-31 | -95.79% |
| 2016-12-31 | -73.98% |
| 2016-09-30 | -69.65% |
| 2016-06-30 | -89.16% |
| 2016-03-31 | -101.18% |
| 2015-12-31 | -3.88% |
| 2015-09-30 | 13.08% |
| 2015-06-30 | -47.86% |
| 2015-03-31 | -114.33% |
| 2014-12-31 | -112.25% |
| 2014-09-30 | -44.43% |
| 2014-06-30 | -167.49% |
| 2014-03-31 | -162.22% |
| 2013-12-31 | -188.65% |
| 2013-09-30 | -276.07% |
| 2013-06-30 | -338.48% |
| 2013-03-31 | -378.34% |
| 2012-12-31 | -368.65% |
| 2012-09-30 | -818.77% |
| 2012-06-30 | -308.42% |
| 2012-03-31 | -274.76% |
| 2011-12-31 | -183.41% |
| 2011-09-30 | -278.36% |
| 2011-06-30 | -211.43% |
| 2011-03-31 | -12892.22% |
| 2010-12-31 | -13006.79% |
| 2010-09-30 | -18503.64% |
| 2010-06-30 | -5200.95% |
| 2010-03-31 | -5564.22% |
| 2009-12-31 | -20787.41% |
| 2009-09-30 | 0.00% |
